ProteoNic
Business Services · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
J.h. Oortweg 19-21, Leiden, South Hollan...Phone Number
(617) 916-5238Website
www.proteonic.nlRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ProteoNic
ProteoNic BioSciences specializes in premium vector technology that enhances the production of complex proteins, including multi-specific antibodies and fusion proteins. Their innovative solutions, such as the 2G UNic vector technology, are designed to improve protein production in various platforms, including CHO, yeast, and mammalian cell lines. The company targets clients in the biotechnology and pharmaceutical industries, particularly those involved in cell and gene therapy manufacturing. ProteoNic's offerings also include licensing opportunities and advanced applications for vaccine production and transgene expression.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ProteoNic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ProteoNic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ProteoNic has new funding data
Check if ProteoNic has recently received funding, and reach out quickly before it becomes old news!
Click to see if ProteoNic had a recent Job posting/layoffs
ProteoNic, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ProteoNic launches new products
Earning: See what the market has to say on ProteoNic recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ProteoNic is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined ProteoNic as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
ProteoNic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ProteoNic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProteoNic.
ProteoNic Tech Stack
A closer look at the technologies used by ProteoNic
ProteoNic News & Media
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure BOSTON, Nov. 3, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through the Biomedical Advanced...ProteoNic Launches 2G UNic Transposon Platform to Support Superior Cell Line Productivity and Ease of Use
Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available for licensing alongside the expansion of 2G UNic compatibility across transposon systems used by biopharma customers.Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers
Leiden, The Netherlands – 1st October 2024 – ProteoNic, a leader in advanced protein expression technology, is pleased to announce an expanded partnership with Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates. Following the successful launch of AbZelectPRO™, a high-producing cell line development platform that combines ProteoNic's 2G UNic® vector technology with Abzena’s host cell line, the CDMO has decided to make this combined platform the standard offerinAbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L
SAN DIEGO, Sept. 26, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, AbZelectPRO™, has significantly reduced its timelines by >30% and improved its overall protein...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ProteoNic
Sign Up For FreeTo access detailed company insights
ProteoNic BioSciences specializes in premium vector technology that enhances the production of complex proteins, including multi-specific antibodies and fusion proteins. Their innovative solutions, such as the 2G UNic vector technology, are designed to improve protein production in various platforms, including CHO, yeast, and mammalian cell lines.... Read More
